No Picture
News

Twist Bioscience and Watchmaker Genomics Announce Partnership to Drive New Applications of High-throughput Genetic Sequencing

SOUTH SAN FRANCISCO, Calif. & BOULDER, Colo.–(BUSINESS WIRE)– #DNA–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Watchmaker… […]

No Picture
News

Four IPOs and a SPAC pitch a new slate of microbiome, cancer and inflammatory drugs to Wall Street

Biotech IPOs are still coming in all sorts of flavors these days.
Just look at what’s on the menu from Friday: There’s Finch Therapeutics, which needs the money to complete a second pivotal trial and start plotting commercialization of its microbiome-b… […]

No Picture
News

Mitochondrial DNA Analysis Is Added to OmniTier’s CompStor® Family of Genomics Secondary and Tertiary Analysis Appliances

SAN JOSE, Calif.–(BUSINESS WIRE)– #DNA–OmniTier announced today that its CompStor® family now supports mitochondrial analysis in both its secondary and tertiary analysis appliances. Accurate identification of the mitochondrial genome and its translo… […]

No Picture
News

With new $106M crossover round, Tenaya preps heart failure programs for the clinic — and maybe an IPO

Less than a year and a half since pulling in its last round of funding, Tenaya Therapeutics is back with a crossover round that could set it up for an IPO down the road.
Private and public investors have now jumped aboard the Tenaya train to the tune o… […]